insulinaem
glycaem
respons
three
forag
poni
carslak
gbr
cardiovers
cathet
recent
becom
commerci
avail
high
success
rate
person
data
transven
electr
cardiovers
tvec
increasingli
use
treatment
atrial
fibril
af
applic
tvec
arrhythmia
current
unknown
data
tvec
procedur
ghent
univers
retrospect
analys
includ
case
dysrhythmia
af
year
old
trotter
year
old
warmblood
persist
atrial
flutter
flutter
rate
year
old
warmblood
persist
atrial
tachycardia
atrial
rate
year
old
warmblood
persist
ventricular
tachycardia
previou
antiarrhythm
treatment
quinidin
sulphat
atrial
tachycardia
magnesium
sulphat
lidocain
amiodaron
ventricular
tachycardia
fail
hors
ultrasoundguid
cathet
placement
tvec
perform
gener
anaesthesia
hors
atrial
flutter
energi
deliveri
ohm
resist
ohm
hors
atrial
tachycardia
ohm
convert
singl
biphas
rwave
synchronis
shock
use
similar
procedur
af
hors
cardiovers
cathet
right
atrium
left
pulmonari
arteri
hors
ventricular
tachycardia
pretreat
amiodaron
one
biphas
rwave
synchronis
shock
ohm
one
cardiovers
cathet
right
ventricl
one
left
ventricl
termin
arrhythmia
hors
unev
recoveri
conclud
tvec
also
use
sustain
atrial
flutter
atrial
tachycardia
ventricular
tachycardia
aortic
ruptur
occur
quit
frequent
friesian
hors
probabl
due
hereditari
disord
aortic
connect
tissu
show
histolog
chang
medial
necrosi
fibrosi
aberr
collagen
morpholog
also
identifi
friesian
megaesophagu
therefor
sever
extracellular
matrix
compon
assess
biochem
mean
hplc
fluorometri
affect
friesian
n
compar
unaffect
friesian
n
warmblood
hors
n
sampl
taken
thorac
aorta
level
ruptur
site
two
locat
caudal
ruptur
well
deep
flexor
tendon
collagen
content
posttransl
modif
collagen
format
includ
lysin
hydroxyl
glycosyl
hydroxylysylpyridinolin
hp
lysylpyridinolin
lp
pyrrol
crosslink
determin
addit
elastin
crosslink
glycosaminoglycan
content
matrix
metalloproteinas
mmp
activ
assess
significantli
increas
mmp
activ
lp
crosslink
lysin
hydroxyl
elastin
crosslink
found
ruptur
site
affect
friesian
unaffect
friesian
show
lower
lysin
hydroxyl
pyrrol
crosslink
tendon
compar
warmblood
hors
conclus
biochem
find
level
ruptur
locat
probabl
due
process
involv
heal
aneurysm
format
import
differ
lysin
hydroxyl
pyrrol
crosslink
flexor
tendon
tissu
friesian
hors
warmblood
support
gener
aberr
connect
tissu
properti
friesian
breed
ploeg
saey
v
delesal
c
one
ducatel
r
de
bruijn
cm
back
w
van
weeren
pr
van
loon
g
chier
k
thorac
interpret
equin
ecg
high
intens
exercis
perform
competit
challeng
motion
artifact
limit
lead
placement
lack
clear
definit
constitut
accept
beat
beat
variabl
whether
experienc
equin
clinician
agre
upon
rhythm
diagnos
ecg
obtain
sanction
race
studi
electrocardiograph
record
norwegianswedish
coldblood
trotter
obtain
sanction
race
event
therefor
analyz
independ
blind
observ
year
experi
read
equin
ecg
number
time
rhythm
event
record
event
classifi
accord
agreedupon
arrhythmia
definit
establish
prior
obtain
ecg
record
r
r
analysi
comput
assist
set
maximum
percent
deviat
agreement
estim
use
kappa
statist
inter
rater
agreement
total
rhythm
event
identifi
reader
event
reader
b
event
reader
c
common
rhythm
event
diagnosi
across
reader
narrow
prematur
complex
compensatori
paus
diagnos
includ
narrow
prematur
complex
without
compensatori
paus
ventricular
prematur
complex
includ
singl
couplet
triplet
supraventricular
prematur
complex
includ
singl
couplet
triplet
episod
atrial
fibril
ventricular
tachycardia
reader
agre
hors
rhythm
diagnosi
sinu
tachycardia
overal
interrat
agreement
absenc
arrhythmia
narrow
prematur
complex
compensatori
paus
spc
poor
kappa
p
highlight
challeng
interpret
ecg
high
intens
exercis
hors
nicotinamid
compon
nad
nadp
play
essenti
role
cellular
atp
produc
mechan
veterinari
medicin
util
prevent
treatment
ketosi
neg
energi
balanc
dairi
cattl
hyperlipemia
catabol
state
common
hors
suffer
variou
condit
object
studi
evalu
effect
nicotinamid
administr
indic
lipid
mobil
metabol
doubl
blind
placebo
control
experiment
trial
hors
fast
strictli
monitor
fashion
earliest
detect
clinic
signific
catabol
state
follow
starvat
h
hors
randomli
alloc
either
treatment
group
control
group
reintroduc
feed
treatment
group
receiv
mgkg
niacin
oral
control
group
receiv
salin
physic
exam
venou
blood
collect
perform
everi
h
first
h
everi
h
addit
h
serum
triglycerid
ffa
bun
insulin
measur
data
analyz
way
repeat
measur
anova
p
consid
signific
hors
toler
starvat
without
complic
anim
uniformli
develop
mild
moder
hypertriglyceridaemia
within
h
starvat
p
refeed
treatment
group
exhibit
significantli
faster
resolut
catabol
indic
bun
ffa
triglycerid
compar
placebo
p
base
promis
result
administr
nicotinamid
evalu
clinic
trial
mucosa
small
intestin
damag
tissu
ischemia
caus
strangul
obstruct
studi
mucos
epithelium
demonstr
villu
tip
suscept
ischemia
extens
disrupt
epithelium
happen
within
three
hour
experiment
ischemia
aim
studi
evalu
correl
alcohol
dehydrogenas
adh
epitheli
damag
hors
small
intestin
strangul
obstruct
includ
blood
sampl
collect
tissu
sampl
resect
surgeri
antimesenter
midst
area
ischem
small
intestin
adh
enzymat
analyz
use
coba
c
tissu
sampl
process
histopatholog
survey
signific
factor
increas
adh
activ
ul
min
max
length
ischem
small
intestin
median
quartil
quartil
complet
disrupt
epithelium
villu
tip
upper
third
crypt
data
suggest
adh
strongli
correl
epitheli
damag
adh
activ
ul
could
valuabl
prognost
marker
resect
involv
small
intestin
owner
surgeon
take
colic
hors
surgeri
certain
individu
anim
appear
predispos
recurr
pastureassoci
lamin
previous
multipl
variabl
investig
lamin
risk
factor
diseas
occurr
studi
aim
investig
lamin
risk
factor
prior
diseas
occurr
poni
year
old
previou
lamin
recruit
bodi
condit
score
height
weight
crest
height
thick
measur
overnight
dexamethason
suppress
test
perform
plasmaserum
concentr
adiponectin
leptin
triglycerid
insulin
insulinlik
growth
factor
igf
creactiv
protein
von
willebrand
factor
vwf
solubl
eselectin
spselectin
assay
followup
obtain
annual
year
ascertain
lamin
develop
data
analys
multivari
logist
regress
total
anim
recruit
studi
median
interquartil
rang
age
year
mare
geld
common
breed
welsh
shetland
cob
overweightobes
bc
ideal
weight
bc
underweight
bc
four
hors
farm
examin
sequenti
day
acut
onset
sever
muscl
fascicul
tachycardia
sweat
period
recumb
kept
paddock
minim
pastur
coverag
extens
growth
malva
parviflora
graze
feed
supplement
minim
hors
euthan
farm
due
rapid
clinic
deterior
hors
refer
hospit
care
determin
sever
myocardi
diseas
generalis
myopathi
hors
euthan
due
prolong
recumb
sever
cardiac
arrhythmia
h
admiss
hors
die
transport
hospit
hors
euthan
onset
clinic
sign
post
mortem
examin
perform
hors
reveal
acut
multifoc
monophas
myonecrosi
cardiac
skelet
muscl
myocyt
glycogen
accumul
absent
pa
stain
hors
acyl
carnitin
profil
perform
serum
hors
equin
control
reveal
increas
acyl
carnitin
case
rel
control
malval
stercul
dihydrostercul
acid
present
malva
parviflora
grossli
increas
sera
case
rel
control
promin
cardiac
compon
differ
acyl
carnitin
profil
suggest
differ
aetiolog
atyp
season
pastur
myopathi
hypothesis
cyclopropen
fatti
acid
found
malva
parviflora
interfer
fatti
acid
betaoxid
hors
neg
energi
balanc
caus
clinic
sign
abnorm
acyl
carnitin
profil
equin
case
close
resembl
human
genet
condit
long
chain
acyl
coa
dehydrogenas
defici
antioxid
enzym
associ
highdens
lipoprotein
blood
neg
acutephas
protein
plasmat
activ
reduc
inflamm
due
consumpt
oxid
consid
possibl
clinic
use
earli
inflammatori
marker
preliminari
valid
studi
hors
serum
activ
measur
clinic
healthi
anim
adult
femal
geld
stallion
foal
use
enzymat
method
adapt
speci
order
preliminarili
assess
possibl
util
marker
system
inflammatori
respons
syndrom
sir
blood
sick
foal
classifi
accord
valid
sir
scale
analyz
intraand
interassay
imprecis
assess
repeat
analysi
pool
sampl
evalu
coeffici
variat
cv
accuraci
indirectli
evalu
linear
dilut
lud
spike
recoveri
test
srt
result
differ
group
healthi
hors
compar
friedmann
test
bonferroni
correct
method
precis
interand
interassay
cv
accur
lud
srt
fit
linear
model
activ
higher
foal
adult
femal
mean
ae
sd
ae
ae
respect
geld
adult
male
ae
ae
respect
sir
foal
activ
lower
lowest
percentil
distribut
healthi
foal
studi
demonstr
method
measur
activ
hors
precis
accur
may
marker
sir
antimicrobi
resist
grow
concern
associ
antimicrobi
use
data
sever
countri
shown
inappropri
use
antimicrobi
common
among
equin
practition
object
studi
investig
antimicrobi
prescrib
practic
equin
practition
austria
germani
switzerland
onlin
questionnair
includ
six
clinic
scenario
sent
member
equin
veterinari
associ
germani
switzerland
austria
antimicrobi
choic
dosag
compar
countri
licens
bodi
current
publish
scientif
guidelin
establish
associ
demograph
factor
use
critic
import
antimicrobi
underdos
logist
regress
analysi
perform
antimicrobi
prescrib
diseas
unlik
bacteri
origin
respond
select
critic
import
antimicrobi
use
third
fourth
gener
cephalosporin
associ
type
practic
p
number
veterinarian
employ
p
fluorquinolon
use
associ
number
veterinarian
employ
practic
p
underdos
occur
dose
compar
licens
dose
rate
compar
current
scientif
guidelin
underdos
practic
major
respond
inappropri
use
antimicrobi
common
critic
import
antimicrobi
chosen
fist
line
antimicrobi
practition
germani
switzerland
austria
underdos
common
problem
caus
fact
scientif
guidelin
match
mostli
lower
dosag
approv
licens
author
equin
coronaviru
ecov
recent
implic
sever
outbreak
lethargi
anorexia
fever
among
adult
hors
purpos
studi
develop
valid
enzymelink
immunosorb
assay
elisa
target
antibodi
spike
protein
ecov
acut
convalesc
serum
sampl
adult
hors
involv
differ
outbreak
use
elisa
starter
accessori
kit
purifi
ecov
sprotein
antihors
igg
use
purpos
optic
densiti
od
valu
field
sampl
well
posit
neg
control
sampl
obtain
use
elisa
elisa
abl
reliabl
repeatedli
classifi
neg
posit
control
serum
sampl
averag
correct
threshold
od
determin
standard
deviat
assay
found
linear
od
rang
intraassay
coeffici
variat
rang
averag
interassay
coeffici
variat
rang
averag
greatest
seroconvers
rate
observ
hors
clinic
sign
compat
ecov
ecov
qpcr
detect
fece
result
show
ecov
elisa
abl
reliabl
detect
antibodi
ecov
could
therefor
valuabl
tool
diagnos
monitor
ecov
outbreak
futur
equin
metabol
syndrom
em
mani
parallel
human
metabol
syndrom
met
met
increas
cardiovascular
risk
incomplet
investig
hors
aim
studi
examin
cardiovascular
system
hors
em
hypothes
em
caus
hypertens
higher
sympathet
tone
rest
exercis
arrythmia
echocardiograph
chang
consist
hypertens
cardiomyopathi
nineteen
poni
diagnos
em
base
histori
lamin
bc
crest
neck
score
increas
insulin
baselin
oral
sugar
test
compar
control
noninvas
blood
pressur
nibp
splenic
volum
heart
rate
variabl
exercis
ecg
ctni
echocardiogram
compar
use
ttest
mannwhitney
u
test
em
poni
show
significantli
higher
hr
p
ae
vs
ae
larger
mean
wall
thick
mwt
p
ae
cm
vs
ae
cm
tendenc
p
larger
rel
wall
thick
rwt
ae
vs
ae
differ
nibp
splenic
volum
heart
rate
variabl
number
prematur
beat
exercis
continu
ecg
ctni
within
laboratori
refer
rang
poni
mwt
correl
nibp
r
p
high
frequenc
power
hf
r
p
low
frequencyhf
ratio
r
p
rwt
correl
insulin
r
p
em
poni
show
myocardi
hypertrophi
correl
insulin
respons
oral
sugar
sympatheticparasympathet
tone
nibp
heterogen
size
group
need
consid
draw
conclus
cardiovascular
chang
em
deserv
attent
motor
neuron
diseas
e
de
castro
j
p
erez
r
zafra
acosta
jl
rivero
c
parr
es
e
aguileratejero
veterinari
school
univers
c
ordoba
ccmcjerez
spain
report
describ
seri
case
equin
motor
neuron
diseas
emnd
associ
intestin
inflamm
herd
young
yearsold
andalusian
hors
n
develop
muscl
atrophi
muscl
fascicul
paresi
weak
weight
loss
onset
clinic
sign
relat
period
restrict
intak
green
forag
apart
poor
bodi
condit
hors
show
symptom
relat
gastrointestin
diseas
preliminari
diagnosi
emnd
made
base
clinic
sign
low
serum
level
vitamin
e
ae
mgdl
normal
rang
mgdl
four
hors
sever
affect
deem
irrecover
euthan
subject
detail
postmortem
exam
confirm
emnd
also
allow
rule
equin
degen
myeloencephalopathi
emnd
diagnos
base
chang
muscl
histopatholog
neurogen
atrophi
spinal
cord
lesion
neuron
chromatolysi
ventral
horn
unexpect
find
postmortem
exam
presenc
enter
sever
eosinophil
infiltr
small
intestin
knowledg
first
report
associ
intestin
diseas
emnd
hors
also
interest
emnd
diagnos
popul
hors
younger
previous
report
although
mechanist
link
could
establish
hypothes
intestin
inflamm
may
led
decreas
absorpt
vitamin
e
thu
favor
develop
emnd
conclus
base
knowledg
gain
case
may
reward
includ
thorough
gastrointestin
evalu
diagnost
workup
emnd
hors
shock
sinc
neg
associ
surviv
import
identifi
manag
colic
hors
shock
index
si
ratio
systol
blood
pressur
heart
rate
hr
shown
indic
sever
shock
sever
speci
aim
studi
evalu
whether
modif
shock
index
ratio
mean
arteri
pressur
map
hr
measur
colic
surgeri
may
serv
prognost
indic
outcom
hors
surgic
record
hors
underw
colic
surgeri
januari
februari
complet
anaesthet
record
evalu
retrospect
equin
surgic
shock
index
essi
calcul
hrmap
essi
measur
first
map
measur
fessi
maxim
ratio
calcul
surgeri
messi
compar
hors
die
surviv
hospit
discharg
roc
analysi
use
establish
area
curv
auc
sensit
specif
essi
predict
outcom
hors
studi
surviv
discharg
fessi
messi
significantli
higher
nonsurvivor
compar
hors
live
discharg
p
p
respect
auc
messi
predict
neg
outcom
confid
interv
messi
specif
posit
likelihood
lr
time
nonsurviv
messi
specif
lr
nonsurviv
conclus
messi
may
valuabl
prognost
tool
hors
colic
purpos
studi
investig
effect
diet
dose
repeat
administr
omeprazol
intragastr
ph
hors
studi
perform
nsw
govern
ethic
permit
six
thoroughbr
instrument
indwel
percutan
gastrotomi
tube
intragastr
ph
measur
two
point
cm
apart
within
ventral
stomach
h
daili
day
hors
alloc
dose
diet
group
crossov
design
high
grainlow
fibr
hg
lf
diet
consist
bw
grain
hay
per
day
divid
two
equal
meal
fed
pm
ad
libitum
hay
hay
fed
mgkg
mgkg
commerci
buffer
omeprazol
formul
administ
po
daili
dose
mgkg
time
ph
higher
hglf
diet
hay
diet
point
vs
p
point
vs
p
time
ph
point
higher
day
day
dose
mgkg
vs
p
mgkg
vs
p
higher
mgkg
mgkg
diet
hay
vs
p
hglf
vs
p
result
suggest
dose
diet
affect
respons
omeprazol
cumul
effect
repeat
administr
present
comparison
three
acut
colic
pain
scale
ga
sutton
r
atamna
mair
koret
school
veterinari
medicin
hebrew
univers
jerusalem
rehovot
israel
bell
equin
veterinari
clinic
kent
uk
valid
reliabl
usabl
scale
need
assess
sever
acut
pain
colic
case
aim
compar
three
scale
sixpoint
equin
acut
abdomin
pain
scale
eaap
fourpoint
scale
mair
smith
sixpoint
numer
rate
scale
nr
forti
short
film
hors
includ
colic
case
control
hors
randomli
present
intern
equin
clinician
websit
randomli
alloc
three
group
particip
use
one
three
scale
five
film
randomli
select
shown
twice
intraobserv
reliabl
speed
eas
use
face
valid
scale
evalu
respons
rate
excel
eaap
nr
group
intraclass
correl
icc
eaap
indic
significantli
better
interobserv
reliabl
compar
confid
interv
ci
nr
kappa
intraobserv
reliabl
eaap
compar
ci
scale
converg
extrem
group
predict
valid
compar
three
scale
regard
usabl
scale
signific
differ
three
scale
respect
time
taken
score
film
speed
eas
use
scale
face
valid
howev
significantli
better
scale
compar
eaap
scale
eaap
show
superior
reliabl
scale
better
face
valid
compar
usabl
test
valid
trigemin
mediat
headshak
syndrom
may
sever
caus
potenti
threat
wellb
hors
one
possibl
etiolog
allerg
rhiniti
random
doubleblind
placebo
control
clinic
trial
effect
cetirizin
antihistamin
season
headshak
perform
lung
protocol
min
consist
rest
walk
trot
record
start
week
treatment
cetirizin
week
placebo
weather
condit
also
record
owner
kept
diari
video
score
amount
shake
overal
amount
shake
ae
start
ae
cetirizin
differ
signific
p
placebo
compar
start
significantli
differ
p
cetirizin
vs
placebo
p
evalu
result
individu
hors
hors
show
improv
cetirizin
hors
show
improv
placebo
compar
factor
like
weather
circumst
taken
account
studi
show
difficulti
use
clinic
trial
syndrom
influenc
weather
mani
factor
suggest
howev
even
cetirizin
benefici
season
headshak
hors
may
diagnost
prove
allerg
etiolog
well
therapeut
also
suggest
followup
hors
clinic
case
reduct
hyperinsulinaem
respons
feed
central
manag
equin
metabol
syndrom
em
aim
studi
compar
insulinaem
glycaem
respons
three
commonli
fed
forag
twelv
poni
mare
geld
mix
breed
mean
age
year
old
rang
median
bodi
condit
score
rang
recruit
maintain
ident
manag
condit
follow
acclim
randomis
crossov
studi
conduct
week
poni
fed
bodi
weight
dri
matter
dm
either
hay
soak
hay
haylag
combin
glucoseinsulin
toler
test
cgit
conduct
glycaem
insulinaem
respons
feed
monitor
h
area
curv
auc
insulin
auci
greater
haylag
compar
hay
p
soak
hay
p
greater
hay
compar
soak
hay
p
auc
glucos
aucg
lower
soak
hay
compar
hay
p
haylag
p
four
poni
classifi
em
posit
base
cgit
result
compar
em
neg
poni
em
posit
poni
greater
auci
hay
p
soak
hay
p
haylag
p
contrast
detect
effect
em
statu
aucg
equival
dm
basi
soak
hay
produc
lowest
haylag
highest
insulinaem
glycaem
respons
feed
insulinaem
effect
forag
greater
poni
em
data
use
guid
feed
equid
em
acer
mapl
genu
tree
compris
speci
worldwid
contain
planttoxin
hypoglycina
proven
caus
highli
fatal
condit
call
atyp
myopathi
hors
poni
earlier
studi
mapletre
sampl
leav
seed
collect
owner
healthi
amaffect
hors
shown
seed
contain
significantli
toxin
leav
concern
whether
mapl
tree
safe
retain
plant
around
paddock
pastur
whether
differ
toxic
differ
speci
aim
present
studi
investig
amount
toxin
differ
mapletre
speci
present
netherland
seed
differ
treespeci
acer
genu
present
arboretum
wageningen
netherland
analys
hypoglycina
speci
belong
platanoidea
subgenu
section
acer
palmata
negundo
subgenera
assay
carri
use
newli
valid
method
base
liquid
chromatographi
coupl
tandem
mass
spectrometri
lcmsm
seed
mapl
tree
belong
platanoidea
contain
hypoglycina
seed
speci
belong
acer
palmata
negundo
subgenera
howev
contain
mgkg
mgkg
mgkg
toxin
respect
result
indic
precis
tree
speci
import
aspect
give
advic
regard
toxic
mapl
tree
consequ
risk
hors
health
hazard
obes
close
relat
local
fat
excess
rather
elev
bodi
weight
per
se
studi
effect
dietinduc
increas
bodi
weight
bodi
fat
accumul
local
determin
shetland
poni
mare
year
old
randomli
divid
control
test
group
fed
either
mainten
diet
ne
high
fat
diet
ne
week
bc
significantli
differ
start
diet
ae
vs
ae
group
twelv
week
start
diet
measur
bc
bodi
weight
ultrasonographi
adipos
tissu
five
differ
locat
retroperiton
axillari
wither
ribey
rump
start
monthli
basi
linear
mixedeffect
model
bonferroni
post
hoc
test
use
statist
p
valu
consid
signific
fat
thick
test
group
alreadi
significantli
higher
compar
control
group
week
measur
period
test
group
show
signific
increas
mean
bodi
weight
p
bc
ae
control
group
remain
test
group
kept
increas
retroperiton
fat
accumul
significantli
time
adipos
tissu
store
axilla
wither
ribey
rump
region
ceas
increas
three
month
measur
conclus
diet
induc
fat
accumul
initi
occur
subcutan
retroperiton
week
fat
accumul
occur
mainli
intraabdomin
aim
studi
determin
residu
effect
week
highenergi
diet
blood
pressur
obes
shetland
poni
mare
four
poni
test
group
receiv
diet
rich
fat
carbohydr
contain
mainten
energi
requir
four
poni
control
group
receiv
diet
contain
mainten
energi
requir
high
energi
diet
result
weight
gain
least
signific
hyperinsulinemia
end
week
period
group
receiv
ad
libitum
hay
week
hayonli
period
oral
glucos
toler
test
ogtt
noninvas
blood
pressur
oscillometr
devic
coccyg
arteri
cardel
determin
gener
linear
mix
model
bonferroni
correct
well
ttest
use
statist
analysi
signific
set
p
systol
diastol
blood
pressur
significantli
higher
test
group
psyst
ae
mmhg
pdiast
ae
mmhg
compar
control
group
psyst
ae
mmhg
pdiast
ae
mmhg
p
p
diastol
blood
pressur
significantli
higher
compar
control
group
p
hyperinsulinem
respons
ogtt
chang
test
group
blood
glucos
area
curv
increas
conclud
short
term
decreas
fat
carbohydr
intak
chang
blood
pressur
obes
hyperinsulinem
shetland
poni
ad
libitum
feed
hay
compar
meal
feed
increas
blood
pressur
lean
shetland
poni
baselin
acth
blood
level
vari
hors
moder
sever
pain
make
diagnosi
ppid
difficult
hors
lamin
pain
condit
therefor
purpos
studi
investig
trhstimul
test
influenc
pain
hors
without
ppid
includ
studi
hors
age
one
year
without
clinic
sign
ppid
moder
pain
due
differ
reason
hors
orthoped
problem
includ
five
hors
lamin
three
hors
colic
hors
judg
accord
modifi
painscor
develop
bussi
ere
et
al
graubner
et
al
dalla
costa
et
al
divid
three
differ
group
accord
pain
level
baselin
acth
cortisol
level
measur
trhstimul
test
perform
previous
describ
hors
reach
painfre
mildli
pain
level
use
control
hors
except
one
baselin
acth
cortisol
level
within
refer
rang
signific
differ
paingroup
control
group
three
differ
pain
group
regard
baselin
acthcortisol
level
acth
cortisol
level
stimul
kruskalwallistest
wilcoxonranktest
therefor
studi
pain
seem
influenc
outcom
trh
stimul
test
despit
differ
manag
system
observ
regard
gestat
length
periparturi
behaviour
mare
foal
mostli
limit
northern
hemispher
studi
conduct
southern
hemispher
data
collect
one
thoroughbr
stud
farm
new
zealand
six
consecut
breed
season
foal
record
time
foal
gestat
length
present
posit
postur
foal
time
taken
foal
stand
nurs
fetal
membran
retent
time
record
gestat
length
mare
studi
ae
day
gestat
length
filli
foal
day
significantli
shorter
colt
foal
day
gestat
length
increas
increas
age
mare
mare
foal
pm
occurr
daytim
foal
foal
produc
live
foal
dystocia
rate
risk
factor
perinat
foal
death
includ
colt
occurr
dystocia
filli
significantli
p
quicker
stand
nurs
colt
nineti
five
percent
mare
expel
fetal
membran
within
four
hour
parturit
whilst
find
similar
result
studi
perform
northern
hemispher
popul
gestat
length
appear
longer
popul
mare
rel
high
number
daytim
foal
base
find
propos
retain
fetal
membran
defin
retent
beyond
hour
postpartum
assess
preval
exerciseinduc
pulmonari
hemorrhag
eiph
elit
endur
hors
competit
endur
hors
geld
mare
age
year
compet
endur
race
differ
categori
km
fei
km
fei
km
fei
bronchoalveolar
lavag
bal
perform
twice
race
day
hors
train
studi
period
addit
hors
match
age
trainer
geld
mare
age
year
bal
perform
compar
environment
manag
control
sampl
bal
fluid
stain
hematoxylineosin
prussian
blue
stain
routin
cytolog
evalu
perform
establish
differenti
leukocyt
presenc
hemosiderophag
criteria
diagnos
eiph
hemosiderophag
bal
fluid
proport
hors
cytolog
evid
eiph
bal
fluid
day
one
month
race
six
hors
eiph
sampl
time
three
eiph
day
race
eiph
one
month
race
contrast
control
hors
hemosiderophag
present
bal
fluid
preval
eiph
elit
endur
hors
contrast
previous
describ
equestrian
disciplin
littl
known
applic
dr
influenc
therapeut
approach
outcom
upper
respiratori
tract
disord
patient
record
retriev
hors
laryng
hemiplegia
lh
hors
dorsal
displac
soft
palat
ddsp
rest
endoscopi
dr
imag
judg
eceim
diplom
independ
respect
grade
lh
therapeut
approach
long
term
follow
perform
mean
telephon
questionnair
interobserv
agreement
cohen
kappa
score
dr
imag
rest
endoscopi
regard
therapeut
approach
rest
endoscopi
dr
lh
case
grade
adjust
neg
dr
posit
dr
result
advis
invas
surgeri
observ
versu
case
lesser
lh
hors
underw
tieback
vcd
vcd
owner
judg
lh
case
preoper
postop
score
regard
perform
improv
regard
nois
ddsp
hors
underw
tieforward
staphylectomi
trainer
judg
preop
postop
regard
perform
mean
race
time
last
race
preop
compar
race
postop
improv
dr
increas
interobserv
agreement
grade
therapeut
approach
lh
successr
lh
surgeri
compar
literatur
wherea
ddsp
surgeri
versu
use
electrolyt
supplement
endur
hors
subject
discuss
evid
use
conflict
aim
studi
investig
electrolyt
supplement
amongst
endur
rider
australia
onlin
questionnair
made
avail
rider
via
australian
endur
rider
associ
aera
websit
social
media
period
two
week
survey
includ
question
relat
type
dose
method
frequenc
time
electrolyt
supplement
level
competit
perform
data
includ
caus
elimin
descript
analysi
perform
potenti
associ
explor
use
mann
whitney
test
p
endur
hors
mainli
purebr
arabian
hors
age
year
respond
supplement
electrolyt
differ
time
train
precompetit
competit
postcompetit
supplement
mainli
use
replac
electrolyt
loss
primarili
suppli
food
past
form
use
salt
block
median
dose
rate
higher
competit
g
compar
train
g
elimin
rate
mainli
due
lame
myopathi
high
heart
rate
pilot
studi
suggest
wide
variat
electrolyt
supplement
endur
ride
australia
howev
larger
number
requir
investig
use
detail
percutan
liver
biopsi
consid
gold
standard
diagnos
equin
hepatopathi
durham
et
al
develop
liver
biopsi
score
system
prove
use
predict
surviv
hors
liver
diseas
thirti
liver
biopsi
collect
hors
suspect
suffer
liver
diseas
januari
may
owner
contact
telephon
determin
surviv
score
assign
biopsi
use
system
develop
durham
et
al
modifi
includ
cholestasi
revers
cytopatholog
paramet
associ
poorer
prognosi
studi
hors
categor
accord
biopsi
score
differ
surviv
group
assess
use
chisquar
test
differ
enzym
concentr
ap
ast
ggt
ldh
survivor
nonsurvivor
group
use
twosampl
ttest
pvalu
consid
signific
present
studi
case
surviv
least
month
signific
differ
surviv
blood
enzym
concentr
differ
biopsi
score
categori
blood
enzym
concentr
survivor
nonsurvivor
use
modifi
liver
biopsi
grade
system
hors
poorer
prognosi
biopsi
score
score
system
easi
appli
score
larger
number
biopsi
would
help
determin
use
grade
system
hors
popul
investig
present
studi
ad
valu
includ
cholestasi
revers
cytopatholog
omeprazol
drug
wide
use
prevent
cure
gastric
lesion
hors
aim
studi
determin
pharmacokinet
behaviour
new
formul
omeprazol
gastroresist
granul
daili
administr
dose
mgkgdie
hors
blood
sampl
taken
prefix
timepoint
hour
posttreat
day
treatment
use
determin
concentrationtim
curv
omeprazol
analys
perform
lcmsm
pharmacokinet
paramet
obtain
winnonlin
softwar
accord
noncompartment
model
day
treatment
cmax
omeprazol
ae
ngml
tmax
median
valu
hour
auc
auc
ae
ae
ngml
h
respect
ae
hour
day
treatment
cmax
ae
ngml
tmax
hour
auc
auc
ae
ae
ngml
h
respect
ae
hour
auc
calcul
hors
subject
model
lower
cmax
auc
obtain
day
could
due
increas
omeprazol
metabol
repeat
administr
longer
tmax
could
explain
rapid
catabol
drug
consequ
flipflop
effect
elimin
rate
faster
absorpt
rate
accumul
drug
occur
day
treatment
data
support
evid
safeti
toler
prolong
administr
report
literatur
nonprim
hepaciviru
nphv
infect
hors
phylogenet
closest
rel
hepat
c
viru
hcv
hcv
major
human
pathogen
caus
acut
chronic
infect
lead
hepatocellular
cirrhosi
carcinoma
hors
howev
clinic
signific
nphv
infect
still
elucid
far
noth
known
rout
transmiss
nphv
infect
sinc
vertic
transmiss
hcv
delin
primari
infect
rout
among
children
studi
aim
survey
vertic
transmiss
nphv
hors
twenti
thoroughbr
broodmar
monitor
foal
season
serum
taken
mare
last
week
prior
parturit
directli
post
foal
umbil
blood
collect
approxim
hour
postpartum
serum
sampl
foal
taken
sampl
analyz
nphv
rna
quantit
realtim
polymeras
chain
reaction
antibodi
nonstructur
protein
nphv
detect
luciferas
immunoprecipit
system
antepartum
four
mare
carri
viral
rna
one
mare
viral
rna
detect
navel
blood
serum
foal
three
rnaposit
mare
vertic
transmiss
observ
moreov
mare
test
posit
serum
antibodi
nphv
respect
foal
also
seroposit
postsuckl
serum
sampl
navel
blood
sampl
antibodi
detect
except
one
mare
first
report
demonstr
vertic
transmiss
nphv
hors
nonprim
hepaciviru
nphv
phylogenet
closest
rel
major
human
pathogen
hepat
c
viru
hcv
hcv
infect
caus
sever
acut
chronic
hepat
potenti
sequela
hepatocellular
cirrhosi
carcinoma
hors
get
infect
nphv
natur
neither
clinic
relev
diseas
rout
transmiss
known
therefor
studi
aim
assess
clinic
cours
equin
immun
respons
experiment
nphv
infect
three
hors
inject
intraven
nphv
posit
plasma
viral
load
rna
copiesml
anim
monitor
clinic
sign
hepat
blood
sampl
drawn
haematolog
blood
biochem
virolog
evalu
weekli
basi
liver
biopsi
taken
evalu
parenchym
chang
within
day
infect
viru
rna
detect
hors
infect
hors
remain
bright
alert
without
show
clinic
sign
diseas
nevertheless
clinicopatholog
data
indic
liver
patholog
one
hors
assess
acut
phase
respons
serum
amyloid
measur
chang
significantli
similarli
cours
immunoglobulin
subset
variabl
individu
hors
hors
show
delay
seroconvers
clear
viru
histopatholog
show
clear
inflammatori
reaction
infect
conclus
experiment
infect
hors
nphv
possibl
viru
clearanc
achiev
hors
although
clinic
sign
diseas
seen
data
support
least
mild
hepat
might
develop
infect
sternal
ebmmsc
obtain
hors
chemic
induc
microscop
assess
day
express
b
tubulin
glial
fibrillari
acid
protein
evalu
western
blot
immunofluoresc
undifferenti
msc
allogen
transplant
surround
fascia
transect
central
portion
anastomot
branch
ramu
communican
later
medial
palmar
nerv
forelimb
healthi
hors
salin
inject
contralater
fascia
nerv
transect
differenti
ebmmsc
display
morpholog
protein
characterist
slc
detach
tissu
cultur
flask
howev
result
poor
viabil
henc
use
msc
histolog
analysi
nerv
day
cell
transplant
reveal
differ
speed
pattern
regener
nerv
msc
salin
ebmmsc
capabl
differenti
slc
possibl
lack
improv
nerv
regener
model
includ
lack
primari
closur
fascia
nerv
transect
method
nerv
transect
interspeci
variabl
studi
regard
method
equin
slc
collect
reevalu
model
peripher
nerv
injuri
hors
need
accur
noninvas
premortem
diagnost
test
equin
grass
sick
eg
current
lack
hypothesis
examin
haematoxylin
eosin
stain
rectal
biopsi
unreli
mair
et
al
vet
rec
examin
rectal
biopsi
immunolabel
bamyloid
protein
precursor
bapp
could
facilit
accur
antemortem
diagnosi
eg
bapp
marker
neuron
injuri
shown
quantit
proteom
analysi
upregul
cranial
cervic
ganglia
ccg
eg
hors
ultim
end
object
determin
diagnost
util
bapp
immunolabel
rectal
biopsi
compar
distribut
densiti
bapp
immunolabel
neuron
perikarya
axon
section
ccg
ileum
eg
hors
control
hors
hors
botul
standardis
score
scheme
grade
use
assess
label
intens
mani
ccg
perikarya
eg
hors
intens
grade
label
control
botul
hors
low
intens
grade
label
intens
label
grade
enter
neuron
identifi
section
eg
hors
control
botul
hors
low
intens
label
grade
summari
bapp
immunoreact
increas
ccg
enter
neuron
perikarya
axon
eg
hors
compar
botul
control
hors
work
underway
determin
whether
bapp
immunolabel
improv
util
rectal
biopsi
premortem
diagnosi
eg
west
nile
viru
wnv
mosquitoborn
zoonot
arboviru
transmit
natur
cycl
mosquito
wild
bird
hors
human
incident
deadend
host
develop
sever
neurolog
disord
close
contact
extracellular
fluid
brain
analysi
cerebrospin
fluid
csf
composit
reflect
biolog
central
nervou
system
cn
impair
enabl
diagnosi
understand
variou
neurodegen
cn
disord
fifteen
csf
sampl
collect
hors
acut
neurolog
symptom
posit
wnv
igm
elisa
sera
csf
sampl
twenti
healthi
hors
without
neurolog
diseas
use
control
biochem
cytolog
paramet
evalu
compar
data
obtain
wnv
affect
hors
seem
follow
normal
distribut
protein
creatinekinas
aspartateaminotransferas
lactatedehydrogenas
alkalinephosphatas
magnesium
glucos
lactat
show
abnorm
level
number
case
none
hors
elev
glucos
level
surviv
modifi
wald
method
ci
opposit
previou
equin
studi
found
neutrophil
pleocytosi
case
measur
data
also
indic
csf
neutrophilia
like
found
parallel
high
protein
content
fisher
exact
test
two
tail
p
csf
find
wnv
neuroinvas
diseas
nonspecif
variabl
neutrophil
like
play
role
develop
inflammatori
respons
brain
damag
increas
enzym
level
reflect
cn
injuri
bloodbrain
barrier
damag
elev
glucos
level
might
secondari
increas
plasma
level
predict
outcom
equin
sarcoid
common
skin
tumor
hors
high
recurr
rate
felin
fibrosarcoma
show
similar
equin
sarcoid
inject
tumor
bed
felin
fibrosarcoma
poxvirus
express
felin
interleukin
il
reduc
recurr
rate
surgic
resect
due
stimul
antitumor
immun
publish
sequenc
felin
equin
il
show
high
homolog
studi
investig
safeti
efficaci
applic
poxvirus
express
felin
interleukin
healthi
hors
hors
equin
sarcoid
four
healthi
hors
inject
subcutan
recombin
poxvirus
express
felin
il
one
hors
develop
temporari
mild
swell
side
inject
signific
differ
clinic
examin
hematolog
profil
cbc
fibrinogen
inject
four
hors
total
number
nine
equin
sarcoid
occult
nodular
treat
twice
seven
day
interv
recombin
poxvirus
express
felin
il
one
sarcoid
vanish
complet
five
show
reduct
size
three
remain
unchang
signific
chang
hematolog
profil
cbc
fibrinogen
treatment
one
hors
develop
mild
fever
day
inject
subsid
follow
day
treatment
equin
sarcoid
recombin
poxvirus
express
felin
il
seem
safe
promis
therapi
option
studi
ongo
substanti
preliminari
result
donkey
refer
histori
one
day
pyrexia
lethargi
respiratori
distress
first
sign
respiratori
diseas
form
cough
shown
four
month
ago
patient
tachypnea
increas
respiratori
effort
moder
bodi
condit
laboratori
find
includ
leukocytosi
hyperfibrinogenemia
sever
hypoxemia
thorac
ultrasound
examin
show
disrupt
pleural
surfac
thorac
radiograph
reveal
sign
mild
interstiti
pattern
patient
die
peracut
diagnost
test
could
perform
gross
patholog
show
multifoc
firm
welldemarc
pale
nodul
throughout
lung
overal
lung
volumin
multifoc
rib
impress
histolog
sever
chronicact
fibrou
interstiti
pneumonia
numer
syncyti
cell
hyperplasia
type
ii
pneumocyt
acut
alveolar
wall
necrosi
evid
clinic
sign
necropsi
find
lack
pathogen
correspond
well
empf
therefor
sampl
frozen
lung
tissu
transmit
viru
examin
pcr
test
neg
subsequ
panherpesviru
nest
pcr
specif
dna
polymeras
gene
conduct
sequenc
obtain
secondround
pcr
product
reveal
ident
compar
asinin
herpesviru
type
sequenc
basic
local
align
search
tool
author
knowledg
first
report
infect
lead
empflik
symptom
donkey
europ
obes
associ
increas
circul
concentr
insulin
leptin
triglycerid
howev
littl
known
relationship
among
morphometr
measur
blood
variabl
relat
obes
object
studi
determin
associ
morphometr
score
system
insulin
leptin
triglycerid
andalusian
hors
crosssect
studi
perform
andalusian
hors
barren
mare
stallion
mean
age
ae
hors
categor
base
bc
obes
bc
morphometr
measur
cm
includ
girth
waist
bodi
length
height
wither
taken
calcul
bodi
ratio
girth
height
girth
length
waist
height
waist
length
concentr
feed
withheld
least
h
sampl
blood
extract
perform
measur
fast
insulin
leptin
triglycerid
concentr
correl
variabl
mean
comparison
carri
thirtythre
hors
obes
bc
morphometr
ratio
leptin
triglycerid
concentr
significantli
higher
obes
hors
entir
sampl
bc
significantli
correl
leptin
triglycerid
morphometr
ratio
girth
length
best
correl
ratio
leptin
correl
insulin
bodi
ratio
triglycerid
correl
waist
height
waist
length
ratio
insulin
correl
girth
height
girth
length
result
show
contrast
studi
carri
breed
bc
andalusian
hors
associ
insulin
level
girth
length
ratio
best
correl
paramet
differ
diagnost
test
determin
insulin
sensit
hors
use
veterinari
practic
besid
measur
fast
insulin
glucos
dynam
test
like
oral
glucos
test
ogt
combin
intraven
insulinglucos
test
cgit
employ
expect
ogt
cgit
may
equal
suitabl
test
insulin
sensit
hors
differ
physiolog
mode
action
ogt
cgit
perform
twelv
healthi
warmblood
hors
hors
differ
sex
age
ae
year
weigh
ae
kg
bodi
condit
score
bc
ae
ogt
perform
gkg
bwt
glucos
administ
via
nasogastr
intub
cgit
perform
inject
mgkg
bwt
glucos
solut
iukg
bwt
insulin
blood
sampl
taken
hour
least
minut
interv
analyz
insulin
glucos
triglycerid
nonesterifiedfattyacid
concentr
time
cours
glucos
insulin
similar
hors
cgit
initi
peak
glucos
insulin
first
sampl
timepoint
follow
continu
similar
decreas
sampl
period
hors
contrast
ogt
four
hors
clearli
respond
exagger
insulin
responsearea
curv
insulin
aucin
ae
ngmlmin
significantli
differ
p
remain
hors
aucin
ae
ngmlmin
relationship
age
sex
weight
bc
ogt
insulin
concentr
present
result
underlin
ogt
cgit
mirror
differ
facet
metabol
respons
glycem
stimulu
autmn
warmblood
weanl
hous
togeth
develop
clinic
sign
suggest
acut
strangl
sampl
one
occas
amiescharco
nasal
swab
cultur
qpcr
equi
ssp
equi
equi
equi
ssp
zooepidemicu
zooepidemicu
clinic
sign
record
includ
fever
nasal
discharg
swollen
region
lymph
node
presenc
ruptur
abscessesaddit
blood
sampl
analys
wbc
count
base
clinic
sign
follow
assess
week
first
occas
appear
time
sampl
coincid
peak
outbreak
anim
cultur
posit
equi
posit
qpcr
cultur
posit
pcr
posit
addit
posit
cultur
zooepidmicu
fever
present
qpcr
posit
foal
purul
nasal
discharg
swollen
submandibular
lymph
node
foal
wbc
count
differ
hors
test
posit
neg
sequi
cultur
p
qpcr
p
qpcr
posit
foal
show
clinic
sign
suggest
acut
strangl
weanl
strangleslik
clinic
sign
posit
cultur
zooepidemicu
neg
qpcr
equi
appear
major
hors
strangl
outbreak
test
posit
equi
cultur
qpcr
may
lack
typic
clinic
sign
acut
diseas
thu
even
sampl
appar
clinic
normal
hors
may
diagnost
valu
strangl
outbreak
tetanu
hors
life
threat
problem
describ
treatment
protocol
includ
applic
antitoxin
penicillin
tranquil
eg
acetylpromazin
muscl
relax
eg
succinylcholin
among
intens
care
measur
disadvantag
use
muscl
relax
hors
tetanu
becom
recumb
therefor
use
diazepam
continu
rate
infus
cri
four
hors
tetanu
treatment
dosag
diazepam
lgkgh
ringer
solut
accord
masset
muscl
spasm
abil
drink
prehend
chew
swallow
feed
durat
treatment
last
two
three
week
concentr
diazepam
nordiazepam
serum
sampl
analys
hplcm
hors
improv
progress
whilst
diazepam
cri
treatment
discharg
hospit
serum
level
diazepam
nordiazepam
rang
lgl
lgl
respect
comparison
therapeut
serum
level
diazepam
nordiazepam
report
approxim
ten
time
higher
human
be
hors
tetanu
seem
benefit
new
approach
treatment
regard
discrep
data
serum
level
human
be
studi
pharmacokinet
diazepam
hors
tetanu
need
movement
disord
often
found
hors
good
clinic
neurolog
orthoped
examin
often
reveal
caus
abnorm
gait
howev
complex
case
assess
whether
hors
orthoped
neurolog
problem
may
challeng
hors
examin
transcrani
magnet
stimul
tm
gait
abnorm
techniqu
assess
function
descend
motor
tract
perform
describ
nollet
et
al
hors
tm
normal
examin
reveal
orthoped
conform
gait
abnorm
hors
howev
case
neurolog
gait
abnorm
diagnos
propriocept
ataxia
suspect
central
vestibular
nervou
problem
pain
neck
lesion
case
abnorm
tm
owner
declin
examin
hors
xray
suspect
region
taken
case
contrast
myelogram
perform
addit
arthrosi
facet
joint
hors
cervic
vertebr
malform
case
trauma
case
fractur
sublux
hematoma
neoplasia
case
intervertebr
disk
diseas
case
found
case
spinal
ataxia
confirm
medic
imag
conclus
transcrani
magnet
stimul
sensit
specif
aid
examin
gait
abnorm
hors
low
resourc
set
obtain
accur
clinicopatholog
data
difficult
method
quantit
blood
smear
evalu
would
posit
addit
diagnost
studi
aim
valid
model
estim
total
differenti
leukocyt
count
microscop
evalu
equin
blood
smear
assess
reliabl
model
clinic
scenario
cytolog
analysi
clinic
haematolog
profil
via
siemen
advia
clinic
pathologist
standard
refer
techniqu
excess
blood
case
use
four
individu
make
blood
smear
slide
examin
two
individu
standardis
method
find
record
dedic
form
includ
number
leukocyt
monolay
field
object
two
unvalid
formula
harvey
jone
use
gener
estim
leukocyt
count
object
blood
smear
hors
examin
mean
leukocyt
count
cellsl
rang
cellslitr
agreement
standard
refer
formula
poor
k
k
could
reliabl
predict
leukocyt
statu
leukopaenia
leukocyt
within
refer
rang
leukocytosi
trend
overestim
algorithm
less
variabl
better
agreement
blood
smear
done
individu
base
upon
result
estim
total
leukocyt
count
use
publish
formula
reliabl
use
make
clinic
decis
analysi
consider
variabl
includ
individu
blood
smear
techniqu
requir
construct
predict
model
mani
studi
deal
welfar
hospit
pet
aim
studi
develop
score
use
assess
qualiti
life
hospit
hors
homogen
group
hors
age
month
year
admit
lyon
veterinari
school
colic
surgic
medic
treatment
studi
paramet
monitor
includ
heart
rate
plasma
concentr
cortisol
pain
score
behaviour
paramet
also
observ
paramet
use
establish
score
qualiti
life
also
includ
factor
abil
access
food
interact
hors
number
neg
event
per
day
also
establish
behavior
profil
aggress
cooper
anxiou
stoic
annoy
hors
base
behavior
paramet
tri
assess
effect
neg
event
base
hors
viewpoint
hors
qualiti
life
improv
time
throughout
hospit
associ
reduct
plasma
cortisol
concentr
hors
valu
significantli
differ
hors
receiv
surgic
treatment
compar
hors
receiv
medic
treatment
hors
becam
cooper
day
refeed
final
studi
highlight
routin
diagnost
test
perceiv
neg
other
transcutan
ultrasonographi
surprinsingli
propos
welfar
scale
base
group
colic
case
studi
offer
practic
approach
better
assess
wellb
hospit
hors
aim
studi
evalu
gfr
hors
differ
age
verifi
differ
studi
approv
ethic
committe
univers
pisa
includ
hors
divid
group
foal
age
day
median
day
group
b
young
hors
age
year
median
year
group
c
old
hors
age
year
median
year
gfr
evalu
use
iohexol
marker
hplcuv
method
complet
blook
work
urinalysi
also
perform
gfr
result
express
mean
standard
deviat
komolgorovsmirnov
appli
verifi
data
distribut
ttest
unpair
data
appli
statist
signific
set
p
gfr
valu
ae
mlminkg
ae
mlminkg
ae
mlminkg
group
b
c
respect
statist
analysi
show
differ
group
result
gfr
obtain
present
studi
compar
literatur
hors
result
slightli
higher
compar
author
foal
might
relat
differ
age
foal
includ
studi
gfr
result
statist
higher
foal
respect
adult
hors
young
old
one
result
might
relat
higher
fluid
intak
foal
adult
hors
gfr
older
popul
result
statist
lower
young
hors
thu
gfr
might
decreas
age
hors
alreadi
report
men
small
dog
two
trotter
stallion
sibl
age
two
year
refer
equin
clinic
free
univers
berlin
erythema
alopecia
crust
diagnosi
immun
mediat
skin
diseas
hors
underw
longterm
treatment
glucocorticoid
azathioprin
two
month
later
hors
develop
hundr
small
wartlik
prolifer
head
neck
trunk
biopsi
hors
taken
histopatholog
reveal
well
demarc
cupshap
epiderm
prolifer
foci
cover
parakeratot
abnorm
form
keratin
deeper
layer
numer
enlarg
cell
cytoplasm
eosinophil
inclusionlik
structur
occasion
intranuclear
basophil
inclus
bodi
strike
besid
cell
peripher
cytoplasm
clear
koilocyt
histopatholog
find
consist
endophyt
papilloma
similar
le
nettyp
describ
immunosuppress
dog
le
net
et
al
caus
distinct
canin
papillomaviru
furthermor
papillomaviru
dna
detect
tissu
sampl
use
broad
rang
pcr
analysi
preliminari
phylogenet
analysi
partial
sequenc
gene
place
viru
genu
lambdapapillomaviru
kind
papilloma
except
rare
describ
hors
literatur
far
retrospect
review
perform
assess
trend
antimicrobi
suscept
bacteri
isol
obtain
within
three
day
first
admiss
equin
univers
colleg
dublin
veterinari
hospit
repeat
isol
bacteria
contemporan
identifi
probabl
environment
contamin
exclud
isol
nasal
screen
programm
includ
chi
squar
test
trend
use
assess
chang
total
proport
sensit
result
studi
period
isol
met
inclus
criteria
chisquar
test
trend
demonstr
signific
chang
suscept
isol
antimicrobi
combin
p
studi
period
subsequ
graphic
identifi
increas
suscept
proport
isol
sensit
test
antimicrobi
confid
interv
respect
year
chisquar
test
trend
limit
antimicrobi
use
system
adult
equin
ceftiofur
cefquinom
enrofloxacin
gentamicin
marbofloxacin
penicillin
polymixin
b
tetracyclin
sulfamethoxazoletrimethoprim
signific
p
respiratori
tract
isol
includ
sinu
nasal
sampl
n
wound
isol
n
respect
demonstr
follow
proport
isol
sensit
ceftiofur
enrofloxacin
gentamicin
marbofloxacin
penicillin
tetracyclin
sulfamethoxazoletrimethoprim
increas
antimicrobi
suscept
identifi
may
attribut
reduct
antimicrobi
resist
alter
antimicrobi
panel
test
reduc
antimicrobi
exposur
prior
present
find
assist
irish
veterinari
practition
select
appropri
antimicrobi
therapi
await
microbiolog
result
respiratori
diseas
wound
case
aim
current
studi
compar
preval
aad
three
referr
hospit
two
southeastern
uk
one
eastern
usa
medic
record
hospit
review
hors
admit
diarrhoea
transfer
isol
unit
due
diarrhoea
hospitalis
includ
aad
defin
develop
diarrhoea
hors
treat
antimicrobi
nongastrointestin
complaint
week
prior
admiss
hors
hospit
admit
hospit
hospit
clinicopatholog
data
antimicrobi
implic
outcom
record
preval
aad
compar
institut
countri
aad
diagnos
hors
diarrhoea
signific
differ
preval
aad
centr
hospit
n
hospit
n
hospit
n
p
signific
differ
preval
aad
countri
uk
usa
p
wide
rang
antimicrobi
antimicrobi
combin
implic
signific
differ
clinicopatholog
data
outcom
identifi
aad
nonaad
hors
apart
rectal
temperatur
higher
hors
aad
versu
p
result
suggest
geograph
differ
preval
aad
may
exist
investig
risk
factor
particular
type
antimicrobi
commonli
implic
pursu
differ
geograph
locat
explor
result
intervent
studi
perform
pastur
hors
poni
sanctuari
eastern
england
describ
volatil
organ
compound
voc
faecal
metabolom
healthi
pastur
anim
characteris
respons
dietari
supplement
enzymerich
malt
extract
erm
faecal
sampl
collect
noninvas
six
week
supplement
erm
control
feed
twice
daili
faecal
metabolom
characteris
use
select
ion
flow
tube
mass
spectrometri
siftm
conjunct
multivari
analysi
order
distinguish
control
fed
erm
princip
compon
analysi
also
employ
observ
trend
group
within
respect
data
set
anim
group
origin
similar
faecal
metabolom
supplement
group
develop
mark
chang
show
twicedaili
use
supplement
suffici
alter
faecal
metabolom
anim
pastur
volatil
faecal
metabolom
domin
organ
acid
alcohol
keton
studi
demonstr
twicedaili
dietari
supplement
erm
may
significantli
alter
profil
voc
pastur
hors
poni
could
import
optimis
therapeut
strategi
prevent
intervent
diseas
associ
graze
pastur
equin
gastric
mucos
ulcer
syndrom
egu
wellknown
diseas
equin
medicin
sever
studi
report
protect
effect
feed
alfalfa
hay
adult
hors
foal
present
studi
effect
feed
alfalfa
chaff
weanl
investig
use
wean
stress
model
induc
gastric
mucosa
lesion
warmblood
weanl
mean
bw
ae
sd
ae
kg
age
month
includ
two
feed
trial
first
trial
consist
three
group
second
trial
two
group
gastroscopi
perform
prior
wean
day
wean
immedi
wean
weanl
alloc
differ
group
first
trial
alfalfa
chaff
n
total
mix
ration
tmr
n
hay
n
second
trial
molass
alfalfa
chaff
n
hay
ii
n
alfalfa
chaffmolass
alfalfa
fed
two
time
day
tmr
ad
libitum
hay
fed
three
time
daili
wean
preval
gastric
mucos
lesion
median
score
percentil
first
trial
median
percentil
second
trial
clinic
sign
discomfort
colic
observ
gastric
lesion
increas
significantli
wean
mostli
affect
region
par
glandulari
special
pyloru
alfalfa
group
weanl
high
preval
gastric
mucos
ulcer
low
sever
score
alreadi
wean
feed
alfalfa
exhibit
posit
effect
stomach
mucosa
increas
significantli
lesion
pyloru
equin
glandular
gastric
diseas
eggd
term
use
classifi
eros
ulcer
diseas
glandular
mucosa
equin
stomach
appear
clinic
distinct
equin
squamou
gastric
diseas
esgd
epidemiolog
risk
factor
develop
eggd
report
object
studi
identifi
possibl
risk
factor
uniqu
associ
eggd
retrospect
crosssect
studi
perform
collect
data
via
webbas
questionnair
hors
owner
studi
includ
case
control
undergon
routin
gastroscopi
univari
multivari
logist
regress
use
identifi
risk
factor
eggd
multivari
model
warmblood
breed
number
caretak
associ
eggd
proport
hors
glandular
lesion
versu
glandular
ulcer
ci
breed
compar
proport
warmblood
proport
hors
glandular
lesion
compar
hors
without
glandular
lesion
ci
hors
caretak
compar
proport
hors
caretak
hors
experienc
previou
colic
reduc
risk
glandular
lesion
compar
hors
previou
colic
cl
identif
specif
risk
factor
allow
specul
potenti
pathophysiolog
mechan
eggd
may
stimul
hypothesisl
investig
pathogenesi
diseas
recurr
rhabdomyolysi
one
signific
caus
poor
perform
racehors
subclin
case
detect
dosag
rest
postexercis
plasmat
ck
hypothes
coverag
larg
muscular
mass
lotion
contain
miner
oxid
may
influenc
physiolog
respons
exercis
limit
muscular
inflamm
induc
train
prospect
random
blind
crossov
studi
twelv
standardbr
trotter
activ
train
underw
two
separ
standard
exercis
test
wear
either
test
lotion
placebo
blood
lactat
heart
rate
rest
postexercis
plasmat
ck
measur
percentag
decreas
lactat
end
recoveri
percentag
increas
ck
hour
post
exercis
calcul
compar
use
pair
tstudent
pair
wilcoxon
signedrank
test
signific
set
p
rel
increas
plasmat
ck
activ
exercis
significantli
milder
hors
wear
design
lotion
compar
placebo
two
hors
subclin
exerciseinduc
rhabdomyolysi
defin
increas
ck
activ
baselin
detect
exercis
perform
placebo
test
lotion
signific
differ
observ
cardiac
lactic
paramet
applic
cutan
lotion
contain
miner
oxid
reduc
muscular
inflamm
induc
exercis
healthi
racehors
could
prevent
occurr
subclin
rhabdomyolysi
evalu
physiolog
mechan
involv
effici
design
product
hors
subject
clinic
recurr
exercis
rhabdomyolysi
requir
investig
lamin
complex
diseas
character
phase
vasodilat
vasoconstrict
clinic
case
difficult
recogn
convent
techniqu
digit
puls
xray
venographi
purpos
studi
evalu
vascular
dynam
doppler
ultrasonographi
submit
peripher
vasculatur
vasodilat
exercis
distal
vasoconstrict
criotheraphi
healthi
hors
cross
section
studi
includ
healthi
adult
hors
differ
breed
design
two
group
made
group
includ
hors
submit
exercis
minut
group
includ
hors
submit
criotherapi
appli
ice
bag
distal
aspect
limb
minut
measur
made
everi
minut
hour
procedur
qualit
spectrum
characterist
quantit
doppler
measur
left
right
later
palmar
digit
arteri
obtain
group
interestingli
increas
arteri
diamet
record
low
resist
pattern
turn
laminar
pattern
group
howev
decreas
peripher
resist
observ
exercis
peripher
resist
pulsatil
index
increas
cryotherapi
moreov
hors
show
revers
diastol
blood
flow
cryotherapi
result
show
peripher
vascular
dynam
chang
evid
healthi
hors
induc
vasodilat
distal
vasoconstrict
identifi
doppler
ultrasonographi
lamin
time
identif
ongo
process
help
focu
treatment
establish
adapt
depend
vascular
dynam
observ
perform
endur
hors
serolog
posit
piroplasmosi
mart
r
barrasa
roquet
r
barrera
lj
ezquerra
veterinari
teach
hospit
univers
extremadura
avda
de
la
universidad
sn
c
acer
spain
equin
piroplasmosi
tickborn
diseas
caus
intraerytrocyt
protozoan
parasit
babesia
cabal
theileria
equi
infect
anim
may
remain
carrier
blood
parasit
long
period
time
act
sourc
infect
tick
introduct
carrier
area
compet
tick
vector
preval
lead
epizoot
spread
diseas
equin
piroplasmosi
consid
endem
area
europ
spain
endur
race
demand
disciplin
consist
achiev
long
distanc
time
fashion
hors
subclin
diseas
carrier
could
potenti
perform
limit
object
studi
determin
seropreval
equin
piroplasmosi
endur
hors
effect
perform
forti
hors
differ
competit
includ
sever
clinic
laboratori
paramet
hors
analyz
presenc
antibodi
confirm
indirect
immunofluoresc
ifi
babesia
theilleria
seropreval
equin
piroplasmosi
test
indirect
inmmunofluoresc
antibodi
thin
blood
smear
neg
hemoparasit
paramet
greater
variat
two
period
pre
post
exercis
concentr
ck
ast
ldh
mean
pcv
competit
lower
group
piroplasmosi
signific
differ
piroplasmosi
posit
neg
hors
perform
presenc
subclin
piroplasmosi
influenc
athlet
perform
endur
hors
